Plasma Hepcidin as a potential informative biomarker of Alzheimer disease and vascular dementia

Plasma Hepcidin as a potential informative biomarker of Alzheimer disease and vascular dementia

Abstract Background Blood-based assays are expected to be integrated into clinical routines across various contexts, including Alzheimer’s disease (AD). Vascular dementia (VaD), which is the second most common cause leading to dementia after AD, could also significantly benefit from this advancement...

Full description

Bibliographic Details
Main Authors: Constance Delaby, Daniel Alcolea, Germain Busto, Audrey Gabelle, Xavier Ayrignac, Karim Bennys, Elena Muiño, Paula Villatoro, Israel Fernández-Cadenas, Nicolas Pradeilles, Shaima El Bounasri, Soraya Torres, Christophe Hirtz, Henrik Zetterberg, Alberto Lleó, Juan Fortea, Sylvain Lehmann
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Alzheimer’s Research & Therapy
Subjects:
Alzheimer’s disease
Blood biomarkers
Hepcidin
NfL
Diagnosis
Vascular dementia
Online Access:https://doi.org/10.1186/s13195-025-01696-9

Internet

https://doi.org/10.1186/s13195-025-01696-9

Similar Items